{
    "clinical_study": {
        "@rank": "65301", 
        "arm_group": [
            {
                "arm_group_label": "Group 1", 
                "description": "Entecavir Therapy"
            }, 
            {
                "arm_group_label": "Group 2", 
                "description": "Lamivudine plus Adefovir Dipivoxil Therapy"
            }
        ], 
        "biospec_descr": {
            "textblock": "serum,plasma and DNA"
        }, 
        "biospec_retention": "Samples With DNA", 
        "brief_summary": {
            "textblock": "Though newly reported HBV infection and HBsAg prevalence in China have greatly decreased,\n      patients who had been chronically infected with HBV, especially those with liver cirrhosis\n      cause great burden on public health care. In view of economic development level, drug\n      availability and lack of independent health economics evidence, the investigators are still\n      unable to give specific guidelines for HBV related compensated liver cirrhosis in China.\n      Therefore, the investigators aim to investigate clinical effects and cost-effectiveness of\n      two early anti-viral therapy strategies on HBV related compensated liver cirrhosis through\n      this prospective, open-label, multicenter and nonrandomized study."
        }, 
        "brief_title": "Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Liver Cirrhosis", 
            "Hepatitis B"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Hepatitis", 
                "Hepatitis A", 
                "Hepatitis B", 
                "Liver Cirrhosis", 
                "Fibrosis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  written informed consent\n\n          -  aged 18-70 years\n\n          -  clinical diagnosis of compensated liver cirrhosis\n\n               1. liver biopsy showing cirrhosis\n\n               2. endoscopy: esophageal varices , exclusion of noncirrhotic portal hypertension\n\n               3. if no biopsy or endoscopy \uff0cshould  meet two of the four:\n\n                    -  Imaging(US, CT or MRI, et al) showing Surface nodularity\uff1a Echogenecity\n                       \uff08spleen pachydiameter > 4.0cm or> 5 costal region\uff09\n\n                         -  PLT < 100\u00d710 < 9 >/L\uff0cno other interpretation\n\n                              -  ALB < 35.0 g/L, or INR > 1.3, or CHE < 5.0KU/L\n\n                                   -  Liver stiffness measurement value > 12.4 kpa\n\n          -  HBeAg(+)with HBVDNA > 10 < 3 > IU/mL or HBeAg(-) wtih HBVDNA > 102 IU/mL\n\n        Exclusion Criteria:\n\n          -  patient with decompensated liver cirrhosis:presence of ascites, variceal\n             hemorrhage,hepatic encephalopathy\n\n          -  allergic to any ingredients of the drugs\n\n          -  patient complicated with alcoholic liver disease, autoimmune liver disease, heretic\n             liver disease, drug induced liver disease,nonalcoholic liver disease or other chronic\n             liver disease.\n\n          -  AFP > 100ng/ml or Cr > 1.5\u00d7ULN\n\n          -  pregnant woman\n\n          -  patient with severe disease or other organ failure\n\n          -  patient with any tumors\n\n          -  patient with sever mental disease.\n\n          -  patients with any disease or condition which the investigator or treating physician\n             feels would interfere with the trial or the safety of the subject"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "compensated HBV Related liver cirrhosis"
            }
        }, 
        "enrollment": {
            "#text": "800", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "October 31, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01720238", 
            "org_study_id": "D1211000039120003"
        }, 
        "intervention": [
            {
                "arm_group_label": "Group 1", 
                "description": "0.5mg qd", 
                "intervention_name": "Entecavir", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Baraclude", 
                    "other manufacturers"
                ]
            }, 
            {
                "arm_group_label": "Group 2", 
                "description": "Lamivudine:100mg qd Adefovir Dipivoxil:10mg qd", 
                "intervention_name": "Lamivudine plus Adefovir Dipivoxil", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Heptodin", 
                    "other manufactures"
                ]
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Adefovir", 
                "Adefovir dipivoxil", 
                "Lamivudine", 
                "Entecavir"
            ]
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Compensated Liver Cirrhosis", 
            "Early Antiviral Therapy", 
            "Cost Effectiveness"
        ], 
        "lastchanged_date": "November 1, 2012", 
        "location": [
            {
                "contact": {
                    "email": "wuxiaoningbs@yahoo.com.cn", 
                    "last_name": "Ning X Wu, Doctor", 
                    "phone": "8610-63138665"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing", 
                        "zip": "100050"
                    }, 
                    "name": "Beijing Friendship Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "yangpin@public.bta.net.cn", 
                    "last_name": "Yuan X Xu, Doctor", 
                    "phone": "8613001185762"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "The First Hospital of Peking University"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "mahui_wj@163.com", 
                    "last_name": "Hui Ma, Doctor", 
                    "phone": "8613671090481"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "PeKing University People's Hopital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "Lilei_1978@yahoo.com.cn", 
                    "last_name": "Guo H Ding, Doctor", 
                    "phone": "8613699119545"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "Beijing YouAn Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Qing X Liu"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "Peking Union Medical College Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Wen Xie"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "Beijing Ditan Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Feng G Chen"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "Beijing 302 Hospital"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Qing Y Xu"
                }, 
                "facility": {
                    "address": {
                        "city": "Beijing", 
                        "country": "China", 
                        "state": "Beijing"
                    }, 
                    "name": "Beijing Tiantan Hospital"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "official_title": "Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis", 
        "overall_contact": {
            "email": "jiamd@263.net", 
            "last_name": "Dong ji Jia, Doctor", 
            "phone": "8610-63139816"
        }, 
        "overall_contact_backup": {
            "email": "youhong30@sina.com", 
            "last_name": "Hong You, Doctor", 
            "phone": "8610-63139019"
        }, 
        "overall_official": {
            "affiliation": "Beijing Friendship Hospital", 
            "last_name": "Dong Ji Jia, Doctor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "China: Beijing Municipal Science and Technology Commission", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "presence of ascites, variceal hemorrhage, hepatic encephalopathy and HCC", 
            "measure": "Decompensation rate of liver cirrhosis", 
            "safety_issue": "No", 
            "time_frame": "3 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01720238"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Beijing Friendship Hospital", 
            "investigator_full_name": "Jia Ji-Dong", 
            "investigator_title": "Director of Liver Research Center", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "child-pugh score", 
                "safety_issue": "No", 
                "time_frame": "1,2 and 3 years"
            }, 
            {
                "measure": "HBVDNA undetected", 
                "safety_issue": "No", 
                "time_frame": "1,2 and 3 years"
            }, 
            {
                "measure": "liver elasticity", 
                "safety_issue": "No", 
                "time_frame": "1, 2, and 3 years"
            }, 
            {
                "measure": "life quality score", 
                "safety_issue": "No", 
                "time_frame": "1, 2 and 3 years"
            }, 
            {
                "measure": "cost-effectiveness", 
                "safety_issue": "No", 
                "time_frame": "1, 2 and 3 years"
            }
        ], 
        "source": "Beijing Friendship Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Peking University First Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Peking University People's Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Beijing YouAn Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Beijing Tiantan Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Beijing Ditan Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Peking Union Medical College Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Beijing 302 Hospital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Beijing Friendship Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2012", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "October 2012"
    }
}